Categories AlphaGraphs, Earnings, Health Care
Key highlights from Bristol Myers Squibb’s (BMY) Q1 2024 earnings results
Bristol Myers Squibb (NYSE: BMY) reported first quarter 2024 earnings results today.
Total revenues increased 5% year-over-year to $11.9 billion. When adjusted for foreign exchange impacts, revenues grew 6%.
GAAP net loss attributable to Bristol Myers Squibb was $11.9 billion, or $5.89 per share, compared to net earnings of $2.3 billion, or $1.07 per share, last year. Adjusted net loss was $4.40 per share.
For the full year of 2024, the company expects total revenues to increase in the low single digits. Adjusted EPS is expected to range between $0.40-0.70.
Prior performance
Listen to the conference calls as they happen. Don't miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.
Most Popular
CL Earnings: Key quarterly highlights from Colgate-Palmolive’s Q2 2024 financial results
Colgate-Palmolive Company (NYSE: CL) reported its second quarter 2024 earnings results today. Net sales increased 4.9% year-over-year to $5 billion. Organic sales increased 9%. Net income attributable to Colgate-Palmolive Company was $731
Key takeaways from Visa’s Q3 2024 earnings report
Credit card behemoth Visa, Inc. (NYSE: V) this week reported mixed results for the June quarter, with earnings matching expectations and sales slightly missing the view. Both numbers grew in
Southwest Airlines (LUV): A look at the airline’s performance in Q2 2024
Shares of Southwest Airlines Co. (NYSE: LUV) were up over 6% on Thursday after the company beat earnings estimates for the second quarter of 2024. The stock has gained 4%
